Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

× No keyword cloud information.

59 in total

1. On the receptors which mediate the hyperpolarization of salivary gland cells of Nauphoeta cinerea Olivier.

Authors: B L Ginsborg; C R House; E M Silinsky
Journal: J Physiol Date: 1976-11 Impact factor: 5.182

2. Dopamine receptor subtypes colocalize in rat striatonigral neurons.

Authors: D J Surmeier; J Eberwine; C J Wilson; Y Cao; A Stefani; S T Kitai
Journal: Proc Natl Acad Sci U S A Date: 1992-11-01 Impact factor: 11.205

3. Homeostatic regulation of dopaminergic neurons without dopamine.

Authors: D James Surmeier
Journal: Proc Natl Acad Sci U S A Date: 2004-08-30 Impact factor: 11.205

4. Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats.

Authors: Keita Ishiwari; Lisa J Madson; Andrew M Farrar; Susana M Mingote; John P Valenta; Michael D DiGianvittorio; Lauren E Frank; Merce Correa; Jörg Hockemeyer; Christa Müller; John D Salamone
Journal: Behav Brain Res Date: 2006-12-21 Impact factor: 3.332

8. Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol.

Authors: C K Meshul; O A Andreassen; C Allen; H A Jørgensen
Journal: Psychopharmacology (Berl) Date: 1996-06 Impact factor: 4.530

9. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons.

Authors: D J Surmeier; W J Song; Z Yan
Journal: J Neurosci Date: 1996-10-15 Impact factor: 6.167

10. Idiopathic Parkinson's disease and depression: a psychosomatic view.

Authors: C J Todes
Journal: J Neurol Neurosurg Psychiatry Date: 1984-03 Impact factor: 10.154

Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).